Jazz Pharmaceuticals plc (JAZZ)
Pre-Market:
| Previous Close | 108.62 |
| Open | 108.30 |
| Bid | 106.93 x 200 |
| Ask | 107.02 x 100 |
| Day's Range | 106.63 - 108.45 |
| 52 Week Range | 103.01 - 146.70 |
| Volume | |
| Avg. Volume | 675,370 |
| Market Cap | 6.743B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | 22.10 |
| EPS (TTM) | 4.84 |
| Earnings Date | Aug 06, 2024 - Aug 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 181.24 |
PR NewswireJazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in the United States. This partnership reinforces Jazz's commitment to supporting the communities in which employees work and live. Life Science Cares is a collective effort to activate the financial and human capital of the life sciences industry across several regions in the U.S. – and partner with nonprofits – to disrupt the cycle of po
Insider MonkeyJazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript May 1, 2024 Jazz Pharmaceuticals plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Krista, and I will be your conference operator today. […]
ZacksJazz (JAZZ) International Revenue Performance Explored
Review Jazz's (JAZZ) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
